Johnson & Johnson (NYSE: JNJ) director receives new deferred share units grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.
Johnson & Johnson director Marillyn A. Hewson reported receiving 214.786 Deferred Share Units on June 9, 2026 as a grant under the company’s Amended and Restated Deferred Fee Plan for Directors. These units represent deferred cash retainers and are to be settled in cash when her board service ends, bringing her total Deferred Share Units to 15,791.877, including amounts accrued as dividend equivalent rights.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HEWSON MARILLYN A
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Share Units | 214.786 | $232.79 | $50K |
Holdings After Transaction:
Deferred Share Units — 15,791.877 shares (Direct, null)
Footnotes (1)
- Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Key Figures
Deferred Share Units granted: 214.786 units
Reference value per unit: $232.79 per unit
Total Deferred Share Units after grant: 15,791.877 units
+2 more
5 metrics
Deferred Share Units granted
214.786 units
Grant/award acquisition on June 9, 2026
Reference value per unit
$232.79 per unit
Fair market value basis for new Deferred Share Units
Total Deferred Share Units after grant
15,791.877 units
Holdings following the June 9, 2026 transaction
Underlying common stock equivalent
214.786 shares
Each Deferred Share Unit tracks one common stock equivalent
Conversion/exercise price
$0.00
Deferred Share Units settled in cash, no exercise price
Key Terms
Deferred Share Units, Amended and Restated Deferred Fee Plan for Directors, dividend equivalent rights
3 terms
Amended and Restated Deferred Fee Plan for Directors financial
"Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors."
dividend equivalent rights financial
"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person."
Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.
FAQ
What insider transaction did Marillyn A. Hewson report for Johnson & Johnson (JNJ)?
Marillyn A. Hewson reported acquiring 214.786 Deferred Share Units for Johnson & Johnson on June 9, 2026. The grant reflects deferral of her cash retainer under the director fee plan and increases her total Deferred Share Units to 15,791.877, including dividend-equivalent accruals.